Showing results (11-20 of 208) with videos related to
Sort By:
Pageof 21
Expert Opinion on Investigational Drugs|February 24, 2025
Mantle cell lymphoma: what clinical progress in the last 5 years?Charbel Soueidy, Jean-Marie Michot, Vincent RibragCancer Imaging : the Official Publication of the International Cancer Imaging Society|December 20, 2005
Role of imaging to choose treatmentChristophe Fermé, Daniel Vanel, Vincent Ribrag, et al.Clinical Lymphoma, Myeloma & Leukemia|November 2, 2020
Can Next-Generation PI3K Inhibitors Unlock the Full Potential of the Class in Patients With B-Cell Lymphoma?Tycel J Phillips, Jean-Marie Michot, Vincent RibragSeminars in Hematology|July 26, 2011
Treatment of younger patients with mantle cell lymphomaStéphanie Harel, Richard Delarue, Vincent Ribrag, et al.Therapeutics and Clinical Risk Management|March 25, 2008
Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumorsJean-Pierre Armand, Vincent Ribrag, Jean-Luc Harrousseau, et al.Leukemia & Lymphoma|September 4, 2008
Primary mediastinal large B-cell lymphomas treated with dose-intensified CHOP alone or CHOP combined with radiotherapyMarcel Massoud, Serge Koscielny, Simona Lapusan, et al.Current Opinion in Oncology|February 8, 2013
Temsirolimus in the treatment of mantle cell lymphoma: frequency and management of adverse effectsKrimo Bouabdallah, Vincent Ribrag, Louis Terriou, et al.Cancers|July 9, 2022
Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell LymphomaKhalil Saleh, Morgane Cheminant, David Chiron, et al.Current Oncology Reports|March 8, 2020
Burkitt and Burkitt-Like Lymphomas: a Systematic ReviewKhalil Saleh, Jean-Marie Michot, Valérie Camara-Clayette, et al.Expert Review of Anticancer Therapy|July 8, 2021
Pembrolizumab in the treatment of refractory primary mediastinal large B-cell lymphoma: safety and efficacyVincent Camus, Camille Bigenwald, Vincent Ribrag, et al.Pageof 21